Lisztwan J - Search Results

1

Knowledge-based virtual screening: application to the MDM4/p53 protein-protein interaction.

Jacoby E, Boettcher A, Mayr LM, Brown N, Jenkins JL, Kallen J, Engeloch C, Schopfer U, Furet P, Masuya K, Lisztwan J. Jacoby E, et al. Among authors: lisztwan j. Methods Mol Biol. 2009;575:173-94. doi: 10.1007/978-1-60761-274-2_7. Methods Mol Biol. 2009. PMID: 19727615

2

The central valine concept provides an entry in a new class of non peptide inhibitors of the p53-MDM2 interaction.

Furet P, Chène P, De Pover A, Valat TS, Lisztwan JH, Kallen J, Masuya K. Furet P, et al. Among authors: lisztwan jh. Bioorg Med Chem Lett. 2012 May 15;22(10):3498-502. doi: 10.1016/j.bmcl.2012.03.083. Epub 2012 Mar 30. Bioorg Med Chem Lett. 2012. PMID: 22507962

3

Tetra-substituted imidazoles as a new class of inhibitors of the p53-MDM2 interaction.

Vaupel A, Bold G, De Pover A, Stachyra-Valat T, Lisztwan JH, Kallen J, Masuya K, Furet P. Vaupel A, et al. Among authors: lisztwan jh. Bioorg Med Chem Lett. 2014 May 1;24(9):2110-4. doi: 10.1016/j.bmcl.2014.03.039. Epub 2014 Mar 22. Bioorg Med Chem Lett. 2014. PMID: 24704029

4

Crystal Structures of Human MdmX (HdmX) in Complex with p53 Peptide Analogues Reveal Surprising Conformational Changes.

Kallen J, Goepfert A, Blechschmidt A, Izaac A, Geiser M, Tavares G, Ramage P, Furet P, Masuya K, Lisztwan J. Kallen J, et al. Among authors: lisztwan j. J Biol Chem. 2009 Mar 27;284(13):8812-21. doi: 10.1074/jbc.M809096200. Epub 2009 Jan 19. J Biol Chem. 2009. PMID: 19153082 Free PMC article.

5

Comprehensive mapping of p53 pathway alterations reveals an apparent role for both SNP309 and MDM2 amplification in sarcomagenesis.

Ito M, Barys L, O'Reilly T, Young S, Gorbatcheva B, Monahan J, Zumstein-Mecker S, Choong PF, Dickinson I, Crowe P, Hemmings C, Desai J, Thomas DM, Lisztwan J. Ito M, et al. Among authors: lisztwan j. Clin Cancer Res. 2011 Feb 1;17(3):416-26. doi: 10.1158/1078-0432.CCR-10-2050. Epub 2010 Dec 15. Clin Cancer Res. 2011. PMID: 21159888

6

The aromatase inhibitor letrozole and inhibitors of insulin-like growth factor I receptor synergistically induce apoptosis in in vitro models of estrogen-dependent breast cancer.

Lisztwan J, Pornon A, Chen B, Chen S, Evans DB. Lisztwan J, et al. Breast Cancer Res. 2008;10(4):R56. doi: 10.1186/bcr2113. Epub 2008 Jul 8. Breast Cancer Res. 2008. PMID: 18611244 Free PMC article.

7

Priming-dependent phosphorylation and regulation of the tumor suppressor pVHL by glycogen synthase kinase 3.

Hergovich A, Lisztwan J, Thoma CR, Wirbelauer C, Barry RE, Krek W. Hergovich A, et al. Among authors: lisztwan j. Mol Cell Biol. 2006 Aug;26(15):5784-96. doi: 10.1128/MCB.00232-06. Mol Cell Biol. 2006. PMID: 16847331 Free PMC article.

8

Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL.

Staller P, Sulitkova J, Lisztwan J, Moch H, Oakeley EJ, Krek W. Staller P, et al. Among authors: lisztwan j. Nature. 2003 Sep 18;425(6955):307-11. doi: 10.1038/nature01874. Nature. 2003. PMID: 13679920 Free article.

9

The von Hippel-Lindau tumor suppressor protein is a component of an E3 ubiquitin-protein ligase activity.

Lisztwan J, Imbert G, Wirbelauer C, Gstaiger M, Krek W. Lisztwan J, et al. Genes Dev. 1999 Jul 15;13(14):1822-33. doi: 10.1101/gad.13.14.1822. Genes Dev. 1999. PMID: 10421634 Free PMC article.

10

Regulation of microtubule stability by the von Hippel-Lindau tumour suppressor protein pVHL.

Hergovich A, Lisztwan J, Barry R, Ballschmieter P, Krek W. Hergovich A, et al. Among authors: lisztwan j. Nat Cell Biol. 2003 Jan;5(1):64-70. doi: 10.1038/ncb899. Nat Cell Biol. 2003. PMID: 12510195

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12 results

Search Page

Filters